| Literature DB >> 22956911 |
Jerome E Lee1, Ju Youn Lee, Jarrett Trembly, Jeffrey Wilusz, Bin Tian, Carol J Wilusz.
Abstract
PARN is one of several deadenylase enzymes present in mammalian cells, and as such the contribution it makes to the regulation of gene expression is unclear. To address this, we performed global mRNA expression and half-life analysis on mouse myoblasts depleted of PARN. PARN knockdown resulted in the stabilization of 40 mRNAs, including that encoding the mRNA decay factor ZFP36L2. Additional experiments demonstrated that PARN knockdown induced an increase in Zfp36l2 poly(A) tail length as well as increased translation. The elements responsible for PARN-dependent regulation lie within the 3' UTR of the mRNA. Surprisingly, changes in mRNA stability showed an inverse correlation with mRNA abundance; stabilized transcripts showed either no change or a decrease in mRNA abundance. Moreover, we found that stabilized mRNAs had reduced accumulation of pre-mRNA, consistent with lower transcription rates. This presents compelling evidence for the coupling of mRNA decay and transcription to buffer mRNA abundances. Although PARN knockdown altered decay of relatively few mRNAs, there was a much larger effect on global gene expression. Many of the mRNAs whose abundance was reduced by PARN knockdown encode factors required for cell migration and adhesion. The biological relevance of this observation was demonstrated by the fact that PARN KD cells migrate faster in wound-healing assays. Collectively, these data indicate that PARN modulates decay of a defined set of mRNAs in mammalian cells and implicate this deadenylase in coordinating control of genes required for cell movement.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22956911 PMCID: PMC3431312 DOI: 10.1371/journal.pgen.1002901
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Figure 1Determination of global mRNA decay rates in PARN knockdown cells.
(A) Abundance of Parn mRNA was determined in CTRL and PARN KD cells by qRT-PCR and normalized to Gapdh mRNA. Error bars represent the standard deviation. (B) Abundance of PARN protein was determined in CTRL and PARN KD cells by western blotting and normalized to GAPDH protein. Relative expression of PARN is indicated below each lane. (C) Exponential decay curves generated from the microarray data for the Gpsm1 mRNA in CTRL and PARN KD cells.
Forty mRNAs are stabilized in PARN knockdown cells.
| Gene ID | Gene symbol | Description | Control t1/2 (min) | PARN KD t1/2 (min) | p value | Fold Change t1/2 | Fold Change Abundance |
| 11541 |
| Adenosine A2b receptor | 80 | 189 | 2.70E-02 | 2.35 | −1.48 |
| 231872 |
| Aminoacyl tRNA synthetase complex-interactor | 156 | 233 | 4.29E-02 | 1.5 | +1.47 |
| 433693 |
| Transcription regulator | 75 | 106 | 2.05E-02 | 1.4 | −1.10 |
| 56317 |
| Anaphase promoting complex subunit 7 | 129 | 208 | 1.84E-02 | 1.61 | −1.07 |
| 223690 |
| Ankyrin repeat-containing domain 54 | 112 | 201 | 7.00E-03 | 1.79 | −1.26 |
| 68566 |
| Calcyon neuron-specific vesicular protein | 246 | 421 | 4.11E-02 | 1.71 | +1.07 |
| 12569 |
| Cyclin-dependent kinase 5, regulatory subunit p35 | 88 | 125 | 4.24E-02 | 1.42 | −1.10 |
| 27886 |
| DiGeorge Syndrome Critical Region 14 | 97 | 133 | 2.88E-02 | 1.37 | −1.04 |
| 353190 |
| Enhancer of mRNA Decapping | 76 | 100 | 9.91E-03 | 1.32 | −1.33 |
| 14082 |
| Fas (TNFRSF6)-associated via death domain | 128 | 153 | 9.53E-03 | 1.2 | −1.24 |
| 67998 |
| Family with sequence similarity 134 | 88 | 151 | 2.66E-02 | 1.71 | −1.54 |
| 14461 |
| Transcription factor | 114 | 159 | 4.63E-02 | 1.39 | −1.25 |
| 11692 |
| Growth factor, augmenter of liver regeneration | 119 | 151 | 4.30E-02 | 1.27 | 1.20 |
| 13972 |
| G-protein beta subunit-like protein | 73 | 145 | 1.94E-02 | 1.98 | −1.20 |
| 67839 |
| G-protein signaling modulator 1 | 149 | 265 | 3.87E-03 | 1.78 | −1.03 |
| 73338 |
| Inositol 1,4,5-triphosphate receptor interacting | 179 | 251 | 4.57E-02 | 1.4 | +1.18 |
| 16529 |
| Potassium channel, subfamily K | 89 | 146 | 3.88E-02 | 1.63 | −1.80 |
| 16534 |
| Calcium-activated potassium channel | 103 | 158 | 2.19E-02 | 1.53 | −1.17 |
| 118445 |
| Kruppel-like transcription factor | 102 | 176 | 3.24E-02 | 1.72 | +1.09 |
| 75660 |
| Lin37 homolog | 107 | 240 | 4.32E-02 | 2.25 | −1.52 |
| 232087 |
| Methionine adenosyltransferase II, alpha | 52 | 111 | 3.73E-03 | 2.12 | −1.27 |
| 211577 |
| Mas-related G-protein coupled receptor | 125 | 279 | 4.21E-02 | 2.24 | −1.95 |
| 100609 |
| Putative DNA methyltransferase | 160 | 270 | 4.41E-02 | 1.69 | +1.07 |
| 27275 |
| Nuclear FMR1 interacting protein | 68 | 99 | 3.25E-02 | 1.44 | −1.06 |
| 54125 |
| DNA-directed polymerase mu | 220 | 340 | 4.56E-02 | 1.54 | −1.16 |
| 56742 |
| Proline/Serine rich protein regulated by p53 | 115 | 158 | 3.50E-02 | 1.37 | −1.01 |
| 545622 |
| protein tyrosine phosphatase | 145 | 262 | 2.07E-02 | 1.8 | −1.62 |
| 170767 |
| Regulatory factor X-associated protein | 109 | 159 | 4.91E-02 | 1.46 | −1.02 |
| 68867 |
| RING-finger ubiquitin ligase | 96 | 144 | 1.98E-02 | 1.5 | −1.52 |
| 244668 |
| Signal-induced proliferation-associated 1 like 2 | 134 | 193 | 4.82E-02 | 1.44 | −1.69 |
| 56389 |
| Syntaxin 5A | 104 | 124 | 2.67E-02 | 1.19 | −1.86 |
| 57752 |
| Transforming acidic coiled-coil containing protein | 109 | 159 | 4.62E-02 | 1.46 | −1.05 |
| 103724 |
| GTPase activator TBC1 domain family | 134 | 184 | 3.34E-02 | 1.37 | −1.01 |
| 68276 |
| Nuclear deadenylase | 71 | 102 | 6.02E-03 | 1.44 | −1.19 |
| 22030 |
| TNF receptor-associated factor 2 | 71 | 98 | 3.60E-02 | 1.38 | −1.12 |
| 106628 |
| Thyroid hormone receptor interactor 10 | 110 | 159 | 3.12E-02 | 1.44 | +1.05 |
| 381560 |
| X Kell blood group precursor related | 117 | 194 | 1.92E-02 | 1.66 | −1.01 |
| 232879 |
| Zinc Finger and BTB domain protein | 96 | 129 | 1.41E-02 | 1.34 | −1.15 |
| 69890 |
| Zinc finger protein 219 | 134 | 193 | 1.37E-02 | 1.44 | +1.04 |
| 12193 |
| Zinc finger protein 36, C3H type-like 2 | 58 | 97 | 2.75E-02 | 1.67 | −1.04 |
Figure 2Independent assays validate the changes in decay in PARN KD cells and verify that stabilization is due to PARN depletion.
mRNA decay rates for (A) Adora2b, (B) Zfp36l2, (C) Gpsm1 and (D) Ankrd54 were determined following Act-D treatment. mRNA abundance at each time point was assessed by qRT-PCR and normalized to that of Gapdh as a stable reference gene. Error bars represent the standard deviation derived from three independent experiments. Half-lives are reported with the standard error at 95% confidence intervals. (E) PARN KD cells were transfected with a control vector (eGFP) or with a construct encoding human PARN and PARN expression was verified by western blot using anti-PARN antibody with GAPDH as a loading control. (F) mRNA decay rates for Zfp36l2 mRNA were evaluated by qRT-PCR in PARN KD cells expressing eGFP or human PARN. Errors represent the standard deviation. Half-lives are reported with the standard error at 95% confidence intervals.
Figure 3PARN modulates Zfp36l2 poly(A) tail length to reduce expression of ZFP36L2 protein.
(A) Total RNA from CTRL or PARN KD cells was treated with RNase H and an oligonucleotide that hybridizes within the 3′UTR of the Zfp36l2 mRNA. The products were separated on a denaturing polyacrylamide gel and detected by northern blotting using a probe against the Zfp36l2 3′UTR. To generate an unadenylated marker, oligo(dT)18 was included in the RNase H treatment for the sample in the first lane. A probe against 5S rRNA was used as a loading control. (B) shows the profile of radioactive counts in the CTRL and PARN KD lanes with approximate size markers indicated on the x-axis. (C) Zfp36l2 mRNA abundance was assessed by qRT-PCR in CTRL and PARN KD cell lines. Error bars represent the standard error of the mean derived from three independent experiments. (D) Western blot showing abundance of ZFP36L2 protein in CTRL and PARN KD cells. Expression was normalized to GAPDH. Relative abundances are indicated along with the standard deviation derived from three independent experiments.
Figure 4PARN acts through the 3′UTR of Zfp36l2 to repress translation.
(A) Luciferase assays were performed in CTRL and PARN KD cells following transfection with empty pLightSwitch_3′UTR vector (Luc) or pLuc-36L2 which bears the Zfp36l2 3′UTR. Error bars are pooled standard deviations derived from three independent experiments. The asterisk indicates a statistically significant difference (p<0.002). (B) Abundance of Luc and Luc-36L2 mRNAs was determined by qRT-PCR and normalized to the abundance of Gapdh mRNA. Error bars represent pooled standard deviations derived from three independent experiments.
Figure 5mRNA stabilization is not correlated with increases in mRNA abundance.
(A) mRNAs that were predicted by the microarray to have significantly altered abundance were evaluated by qRT-PCR. Fold change in abundance in the PARN KD cell line as compared to the CTRL cells is shown. Error bars represent the pooled standard deviation from three independent experiments. Asterisks indicate statistically significant differences (p<0.05). (B) Scatter plot of fold change in abundance versus fold change in mRNA half-life for those mRNAs that showed significant changes in stability in PARN KD cells. The transcripts indicated in orange had increased stability following PARN KD, those in green were destabilized by PARN KD. Transcripts shown in grey had no significant change in half life. (C) The abundance of four transcripts that were stabilized following PARN depletion was evaluated in CTRL and PARN KD cell lines by qRT-PCR. The error bars represent the pooled standard deviation derived from four experiments. Statistically significant differences (p<0.05) are indicated by an asterisk. (D) The fold change in mRNA half-life for each mRNA is shown for comparison. This bar chart is derived from the same data as shown in Figure 2. (E) The abundance of newly transcribed pre-mRNAs was assessed by qRT-PCR and normalized to abundance of 7SL RNA. Statistically significant differences from the control (p<0.02) are indicated by asterisks.
Figure 6PARN knockdown results in enhanced wound healing.
(A) CTRL and PARN KD were grown to confluency and displaced from the plate by scratching with a pipette tip. Wounds were allowed to heal over a period of eight hours and then the number of cells that had migrated into the wound was counted. (A) Brightfield images of the wounds in each cell line before and after incubation. (B) Graph showing the quantification of triplicate wound healing assays similar to those shown in (A). The error bars represent the standard deviation. (C) Graph showing the number of cells migrating into the wound in CTRL and PARN KD cells transfected with empty vector, and PARN KD cells transfected with a vector encoding human PARN. Error bars represent the standard deviation. All differences were statistically significant (*p<0.05).